Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

920
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

882
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

336
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

966
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

312
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of next-generation wireless skin temperature sensors during exercise-heat stress.

Experimental physiology·2026
Same author

Feasibility and impact of personalized therapy for obstructive sleep apnea in patients with acute coronary syndrome: a pilot randomized controlled trial.

Pilot and feasibility studies·2026
Same author

The Measurement and Application of Critical Speed and D' in Running: A Scoping Review.

Sports medicine (Auckland, N.Z.)·2026
Same author

Current and novel device-led approaches for targeted obstructive sleep apnea screening, diagnosis, treatment, and long-term management.

Expert review of medical devices·2026
Same author

Blood pressure response with obstructive sleep apnoea treatment: mandibular advancement device versus continuous positive airway pressure.

Expert review of medical devices·2026
Same author

Effect of nighttime bedroom temperature on heart rate variability in older adults: an observational study.

BMC medicine·2025

Related Experiment Video

Updated: Feb 1, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

643

Elevated Oxygen Uptake Recovery Ratio In Heart Failure Has Poorer Prognostic Outcomes.

Iain W Smith1, Glenn M Stewart2, Surendran Sabapathy3

  • 1School of Health Sciences and Social Work, Griffith University, Gold Coast, Qld, Australia; Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Qld, Australia.

Heart, Lung & Circulation
|January 30, 2026
PubMed
Summary

A new oxygen consumption recovery ratio (V˙O2RR) from cardiopulmonary exercise tests (CPET) can predict heart failure (HF) outcomes. This simple metric offers valuable prognostic information for HF patients.

Keywords:
Cardiopulmonary exercise testingHeart failureRecovery kinetics

More Related Videos

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Related Experiment Videos

Last Updated: Feb 1, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

643
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Pulmonary Medicine

Background:

  • Impaired oxygen kinetics post-exercise are linked to poor prognosis in heart failure (HF).
  • Current clinical interpretation of cardiopulmonary exercise tests (CPET) for HF patients does not routinely use oxygen recovery parameters.
  • There is a need for simple, effective prognostic markers in HF management.

Purpose of the Study:

  • To identify a straightforward post-exercise oxygen kinetic parameter for HF prognosis.
  • To evaluate the prognostic capability of the novel oxygen consumption recovery ratio (V˙O2RR) in HF patients.
  • To assess the association between V˙O2RR and major cardiac-related events.

Main Methods:

  • A cohort of 140 individuals with HF undergoing CPET was analyzed.
  • A new parameter, V˙O2RR (V˙O2 recovery / V˙O2peak), was calculated.
  • The predictive value of V˙O2RR for 24-month transplant-free survival was examined using logistic regression.

Main Results:

  • Higher V˙O2RR values correlated with reduced exercise capacity and ventilatory efficiency.
  • A V˙O2RR of ≥1.00 was associated with worse exercise performance.
  • V˙O2RR independently predicted poorer transplant-free survival in HF patients.

Conclusions:

  • The V˙O2RR is a readily calculable metric from CPET with significant prognostic value in HF.
  • Combining V˙O2RR with V˙O2peak enhances outcome prediction in HF populations.
  • This parameter can aid in risk stratification and clinical decision-making for HF patients.